Option chain shows key data for North Bud Farms's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for North Bud Farms.

North Bud Farms (OTC:NOBDF) Stock, Option Chain

North Bud Farms Inc owns a state-of-the-art purpose-built cannabis production facility located on approximately 135 acres of agricultural land in Low, Quebec, Canada. The Low, Quebec facility currently has approximately 24,500 square feet of licensed indoor cultivation space; the company has submitted its licence amendment application to Health Canada to add an additional approximately 1,000,000 square feet of outdoor cultivation space.

Cannabis

Government

News

Penny Stocks

Regulations

Markets

NOBDF

CSE:NBUD

North Bud&#39;s Quebec Facility Obtains Health Canada&#39;s Cultivation License

Management

North Bud Farms Hires Jeffrey Stoss As Chief Financial Officer

Movers & Shakers

Intraday Update

Movers

Trading Ideas

General

AEMD

AFOM

AKER

ALRM

ALTM

APDN

AREX

ASIX

ASPCF

AUSAF

AXLA

BCEI

BLGVF

BNKPF

BRTX

BRVVF

BUDZ

BVTK

CADMF

CCORF

CDEV

CGIX

CHOOF

CIRX

CNAB

CNPOF

CRVYF

CRXPF

CRZO

CTRA

CVEO

CVSI

CYDVF

DSWL

DYNT

EARS

ENBL

ENLC

ENZN

ETRN

EUROPEAN ELECTRIC METALS by European Electric Metals Inc.

EVXXF

EWLL

EXPE

EXTN

EZPW

FUTURE FARM TECHNOLOGIES by Future Farm Technologies Inc.

FFRMF

FOSL

FPRX

GBHL

GGBXF

GGTTF

GHSI

GLDFF

GLOG

GLOP

GRJVF

GRNQ

GRTD

GTCH

GTLS

GYNAF

HEXO

HRTFF

IIVI

ILUS

IMHC

INAP

INLB

INQD

IONKF

IVITF

JAGX

JWCAF

KCLI

KGET

KLXE

KPOC

LBRT

AMERICAN LITHIUM CORP ORD by American Lithium Corp.

LIACF

LIQT

LKSD

LQSIF

Stocks That Hit 52-Week Lows On Tuesday

NORTH BUD FARMS INC NPV by North Bud Farms Inc.

North Bud Farms Inc

"We are thrilled with the tremendous progress we've made in collaboration with Tesla, having already achieved, as of December 15th, 350,000 paid subscribers", said Robert Ellin, CEO of LiveOne. "This partnership allows us to leverage our entire tech stack, including AI, to deliver highly personalized experiences, further enriching our users' engagement and driving business growth."

LiveOne-Tesla Partnership Hits 350K Paid Subscribers, Highlights $16M Cash Position

B of A Securities analyst Jessica Reif Ehrlich maintains Fox (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FOXA#NASDAQ">FOXA</a>) with a Buy and raises the price target from $50 to $55.

Price Target

Analyst Ratings

FOXA

B of A Securities Maintains Buy on Fox, Raises Price Target to $55

ONCY

Oncolytics Biotech Reveals Presentation Of Two Data Sets Through Two Abstracts Showcasing Pelareorep's Potential In Difficult-to-treat Gastrointestinal Cancers At ASCO

B of A Securities analyst Justin Post upgrades Expedia Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXPE#NASDAQ">EXPE</a>) from Neutral to Buy and raises the price target from $187 to $221.

Upgrades

B of A Securities Upgrades Expedia Group to Buy, Raises Price Target to $221

Shareholder Firstlight Management Urges Board Of Sotera Health For Sale Of Nelson Labs Subsidiary

PERI

Perion And Experian Team Up To Boost AI-Powered Ad Solutions Across Devices

PLTR

Pray.com And Palantir Join Forces To Enhance Multilingual Faith-Based Content Using Advanced AI Technology

B of A Securities analyst Tazeen Ahmad initiates coverage on KalVista Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KALV#NASDAQ">KALV</a>) with a Buy rating and announces Price Target of $22.

Initiation

KALV

B of A Securities Initiates Coverage On KalVista Pharma with Buy Rating, Announces Price Target of $22

Rosenblatt analyst Hans Mosesmann maintains Micron Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>) with a Buy and maintains $250 price target.

Rosenblatt Maintains Buy on Micron Technology, Maintains $250 Price Target

Beyond the strategic partnership with Sysco, Square also announced new features to help restaurants run their businesses easily and efficiently. These features are currently rolling out to sellers, with full availability in early 2025.

Square Enters New Partnership With Sysco

B of A Securities analyst Saurabh Pant maintains Baker Hughes (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKR#NASDAQ">BKR</a>) with a Buy and raises the price target from $42 to $48.

B of A Securities Maintains Buy on Baker Hughes, Raises Price Target to $48

Citigroup analyst Paul Lejuez initiates coverage on On Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ONON#NYSE">ONON</a>) with a Neutral rating and announces Price Target of $65.

ONON

Citigroup Initiates Coverage On On Holding with Neutral Rating, Announces Price Target of $65

Mizuho analyst John Baumgartner maintains Nomad Foods (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOMD#NYSE">NOMD</a>) with a Outperform and lowers the price target from $28 to $24.

NOMD

Mizuho Maintains Outperform on Nomad Foods, Lowers Price Target to $24

Barry will continue to report to ICON's Chief Executive Officer, Steve Cutler.

ICLR

ICON Appoints Barry Balfe As COO

Citigroup analyst Paul Lejuez initiates coverage on Academy Sports (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASO#NASDAQ">ASO</a>) with a Buy rating and announces Price Target of $65.

Citigroup Initiates Coverage On Academy Sports with Buy Rating, Announces Price Target of $65

<ul>
<li>Oklo and Switch have signed one of the largest corporate power agreements in history, a 12-gigawatts non-binding Master Power Agreement.</li>
<li>This milestone agreement demonstrates a shared commitment to advancing sustainable energy solutions, supporting data center growth, and driving industry-wide decarbonization.</li>
<li>Oklo's Aurora powerhouses will provide reliable, clean energy for Switch's cutting-edge AI, cloud, and enterprise data center infrastructure.</li>
</ul>

OKLO

Oklo And Switch Partner To Deploy 12 GW Of Advanced Nuclear Power

Adjusted operating profit is now expected to range between down 4 percent and down 2 percent in constant currency, compared to the previous range of between down 2 percent and flat in constant currency, reflecting higher investment levels.&nbsp;

Guidance

General Mills Revises FY25 Adjusted EPS Outlook Range To Down 3% To Down 1% In Constant Currency, Compared To Previous Range Of Down 1% To Up 1%

Biotech

Health Care

ORKA

Oruka Therapeutics Announced That It Is Expected To Be Added To The Nasdaq Biotechnology Index (NBI), Oruka's Addition Will Become Effective Prior To Market Open On December 23

ABM Sees FY25 Adjusted EPS Outlook Of $3.60-$3.80 Vs. $3.66 Est., Adjusted EBITDA Margin Of 6.3% to 6.5%

Citigroup analyst Steven Zaccone upgrades Ollie's Bargain Outlet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OLLI#NASDAQ">OLLI</a>) from Sell to Buy and raises the price target from $64 to $133.

OLLI

Citigroup Upgrades Ollie's Bargain Outlet to Buy, Raises Price Target to $133

North Bud Farms

Comments

North Bud Farms

North Bud Farms (NOBDF) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga